Curriculum Vitaes

ishikawa hiroaki

  (石川 浩章)

Profile Information

Affiliation
School of Health Sciences Faculty of Medical Technology, Fujita Health University
Degree
博士(医学)

J-GLOBAL ID
200901065684943874
researchmap Member ID
1000289480

Research Interests

 2

Committee Memberships

 1

Awards

 1

Papers

 27
  • Hiroya Yamada, Eiji Munetsuna, Mirai Yamazaki, Genki Mizuno, Nao Sadamoto, Yoshitaka Ando, Ryosuke Fujii, Kazuya Shiogama, Hiroaki Ishikawa, Koji Suzuki, Yohei Shimono, Koji Ohashi, Shuji Hashimoto
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 33(10) 11431-11442, Oct, 2019  Peer-reviewed
    Fructose consumption is rising globally, but maternal high fructose intake might adversely affect offspring. Our previous report demonstrated that excess maternal fructose intake impairs hippocampal function in offspring, indicating that the hippocampi of offspring are highly sensitive to maternal fructose. Here, we examined the effect of maternal high fructose on mitochondrial physiology and uncoupling protein (UCP) expression. Rat dams received a 20% fructose solution during gestation and lactation. Immediately after weaning, offspring hippocampi were isolated. Maternal high fructose consumption attenuated the mitochondrial O2 consumption rate and stimulated lipid hydroperoxide production in the hippocampi of offspring. Reduced Ucp5 and mitochondrial transcription factor A (Tfam) mRNA levels were also observed after maternal exposure to fructose. We assessed the promoter regions of both genes and found that this treatment enhanced DNA methylation levels. In addition, luciferase assays showed that this DNA methylation could reduce the transcription of both genes. Chromatin immunoprecipitation analysis demonstrated that specificity protein 1 binding to the Ucp5 promoter regions was reduced by DNA methylation. In addition, Ucp5 knockdown induced the up-regulation of reactive oxygen species levels in a rat brain glioma cell line, whereas reduced O2 consumption was observed with Tfam knockdown. Maternal high fructose intake thus induces reduced O2 oxygen consumption and increases oxidative stress in offspring, at least partly through epigenetic mechanisms involving Ucp5 and Tfam.-Yamada, H., Munetsuna, E., Yamazaki, M., Mizuno, G., Sadamoto, N., Ando, Y., Fujii, R., Shiogama, K., Ishikawa, H., Suzuki, K., Shimono, Y., Ohashi, K., Hashimoto, S. Maternal fructose-induced oxidative stress occurs viaTfam and Ucp5 epigenetic regulation in offspring hippocampi.
  • Eiji Munetsuna, Hiroya Yamada, Mirai Yamazaki, Yoshitaka Ando, Genki Mizuno, Yuji Hattori, Nao Sadamoto, Hiroaki Ishikawa, Yoshiji Ohta, Ryosuke Fujii, Koji Suzuki, Shuji Hashimoto, Koji Ohashi
    The Journal of nutritional biochemistry, 67 44-50, May, 2019  Peer-reviewed
    Global fructose consumption is on the rise; however, maternal high-fructose intake may have adverse effects on offspring. We previously demonstrated that excessive fructose intake by rat dams altered steroidogenic gene transcription in the hippocampus of offspring. Herein, we examined how maternal high-fructose intake influences the regulation of adrenal glucocorticoid levels in offspring. Rat dams received 20% fructose solution during gestation and lactation. After weaning, the offspring were provided normal water. Maternal high-fructose intake did not alter mRNA expression levels of adrenal corticosterone-synthesizing and corticosterone-inactivating proteins or the circulating adrenocorticotropic hormone levels of offspring at postnatal day (PD) 21; however, it increased circulating corticosterone levels and decreased mRNA and protein levels of adrenal 5α-reductase type 1 and 11β-hydroxysteroid dehydrogenase type 2 in offspring at PD160. Furthermore, maternal high-fructose intake enhanced DNA methylation of the adrenal 5α-reductase 1 promoter region in PD160 offspring. Thus, maternal high-fructose intake was found to affect adrenal steroid hormone clearance in adult offspring - at least in part - through epigenetic mechanisms.
  • Mari Kondo, Hiroya Yamada, Eiji Munetsuna, Mirai Yamazaki, Takeshi Hatta, Akihiko Iwahara, Koji Ohashi, Hiroaki Ishikawa, Yoshiki Tsuboi, Takashi Inoue, Ryosuke Fujii, Koji Suzuki
    Archives of Gerontology and Geriatrics, 82 155-160, May, 2019  Peer-reviewed
  • Fujii R, Yamada H, Munetsuna E, Yamazaki M, Ando Y, Mizuno G, Tsuboi Y, Ohashi K, Ishikawa H, Hagiwara C, Maeda K, Hashimoto S, Suzuki K
    Am J Clin Nutr, 110(5) 1213-1219, 2019  Peer-reviewed
  • Fuji R, Yamada H, Munetsuna E, Yamazaki M, Mizuno G, Tsuboi Y, Ohashi K, Ishikawa H, Ando Y, Hagiwara C, Maeda K, Hashimoto S, Hamajima N, Suzuki K
    Nutrition, 65 15, 2019  Peer-reviewed
  • Fuji R, Yamada H, Munetsuna E, Yamazaki M, Ohashi K, Ishikawa H, Maeda K, Hagiwara C, Ando Y, Hashimoto S, Hamajima N, Suzuki K
    J Epidemiol, In press, 2019  Peer-reviewed
  • Hiroaki Ishikawa, Hiroya Yamada, Kanako Kondo, Takeru Ota, Mirai Yamazaki, Yoshitaka Ando, Genki Mizuno, Eiji Munetsuna, Koji Suzuki, Ryoji Teradaira, Koji Ohashi
    Annals of clinical biochemistry, 56(1) 49-55, Jan, 2019  Peer-reviewed
    BACKGROUND: MicroRNAs are present not only in exosomes but also in high-density lipoprotein (HDL) and have the potential as biomarkers for various diseases. Various purification methods have been developed to quantify HDL-miRNAs; however, they are unsuitable for clinical applications. Therefore, we aimed to establish a simpler analytical method to quantify HDL-miRNAs for clinical applications. METHODS: We purified HDL fraction from pooled plasma using a three-step protocol consisting of ultracentrifugation, phosphotungstic acid/MgCl2 precipitation and desalting/buffer exchange followed by the quantification of HDL-miRNAs by quantitative real-time PCR. In order to establish a method to quantify HDL-miRNAs by quantitative real-time PCR, we prepared standard curves for miR-223 and miR-92. The HDL-miRNAs of 10 volunteers were assessed. RESULTS: Exosomes and LDL were not detected in the purified HDL fraction. Furthermore, we confirmed that only HDL was purified and that the HDL recovery rate of our method was at least approximately 50%. The threshold cycle values of miR-223, miR-92, miR-146a and miR-150 in the same subject were 32.11 ± 0.58, 32.50 ± 0.35, 34.30 ± 0.70 and 34.91 ± 0.77, respectively ( n = 10). The coefficient of variation values for these miRNAs were 1.08-2.21%. In addition, the standard curve for the quantitative analysis of miRNAs showed high linearity (30-30,000 copies/ μL) with a correlation coefficient of >0.99. The concentrations of HDL-miR-223 and HDL-miR-92 in the plasma of 10 subjects were 1.98 ± 0.32 and 0.90 ± 0.14 copies/mL (×104). CONCLUSIONS: We established a simple method for quantifying HDL-miRNAs and improved the sample processing capacity compared with conventional methods.
  • Eiji Munetsuna, Hiroya Yamada, Yoshitaka Ando, Mirai Yamazaki, Yoshiki Tsuboi, Mari Kondo, Genki Mizuno, Hiroaki Ishikawa, Keiko Sugimoto, Keisuke Osakabe, Naohiro Ichino, Koji Ohashi, Nobuyuki Hamajima, Koji Suzuki
    Annals of clinical biochemistry, 55(4) 437-445, Jul, 2018  Peer-reviewed
    Purpose It has been demonstrated that circulating microRNA profiles are affected by physiological conditions. Several studies have demonstrated that microRNAs play important roles in the regulation of adiposity. However, few have investigated the relationship between circulating microRNAs and obesity, which has become a major public health problem worldwide. This study investigated the association between circulating microRNAs and obesity in a Japanese population. Methods Obesity parameters, such as subcutaneous and visceral fat adipose tissue, body fat percentage, and body mass index were assessed in a cross-sectional sample of 526 participants who attended health examinations in Yakumo, Japan. In addition, five circulating microRNAs (miR-20a, -21, -27a, -103a, and -320), which are involved in adipocyte proliferation and differentiation, were quantified using real-time polymerase chain reaction amplification. Results We compared the circulating microRNA concentrations in a percentile greater than 75th (high) with below the value (low) of subcutaneous adipose tissue, visceral fat adipose tissue, body mass index, and per cent body fat. For visceral fat adipose tissue, significant decrease in miR-320 expression was observed in high group. Also, for body mass index, significant change of miR-20a, -27a, 103a, and 320 expression level was observed in high group. Multiple linear regression analysis demonstrated that circulating levels of some microRNA such as miR-27a were significantly associated with subcutaneous adipose tissue, visceral fat adipose tissue, and body mass index. Conclusions Our findings support the need for further studies to determine whether such changes are consistent across different populations and whether the identified microRNAs may represent novel biomarkers to predict the susceptibility and progression of obesity-related disorders.
  • Munetsuna E, Yamada H, Yamazaki M, Ando Y, Mizuno G, Ota T, Hattori Y, Sadamoto N, Suzuki K, Ishikawa H, Hashimoto S, Ohashi K
    Life Sc, 202 117-123, 2018  Peer-reviewed
  • Tsuboi Y, Yamada H, Munetsuna E, Yamazaki M, Mizuno G, Murase Y, Ohashi K, Ishikawa H, Kondo M, Inoue T, Hashimoto S, Hamajima N, Suzuki K
    J Atheroscler Thromb, 25(12) 1231-1239, 2018  Peer-reviewed
  • Yamazaki M, Yamada H, Munetsuna E, Ishikawa H, Mizuno G, Mukuda T, Mouri A, Nabeshima T, Saito K, Suzuki K, Hashimoto S, Ohashi K
    FASEB J, 32 2549-2562, 2018  Peer-reviewed
  • Genki Mizuno, Eiji Munetsuna, Hiroya Yamada, Yoshitaka Ando, Mirai Yamazaki, Yuri Murase, Kanako Kondo, Hiroaki Ishikawa, Ryoji Teradaira, Koji Suzuki, Koji Ohashi
    ENDOCRINE RESEARCH, 42(1) 71-77, 2017  Peer-reviewed
  • Hiroaki Ishikawa, Hiroya Yamada, Nao Taromaru, Kanako Kondo, Ayuri Nagura, Mirai Yamazaki, Yoshitaka Ando, Eiji Munetsuna, Koji Suzuki, Koji Ohashi, Ryoji Teradaira
    ANNALS OF CLINICAL BIOCHEMISTRY, 54(1) 134-142, Jan, 2017  Peer-reviewed
  • Mirai Yamazaki, Eiji Munetsuna, Hiroya Yamada, Yoshitaka Ando, Genki Mizuno, Yuri Murase, Kanako Kondo, Hiroaki Ishikawa, Ryoji Teradaira, Koji Suzuki, Koji Ohashi
    LIFE SCIENCES, 149 146-152, Mar, 2016  Peer-reviewed
  • Koji Ohashi, Eiji Munetsuna, Hiroya Yamada, Yoshitaka Ando, Mirai Yamazaki, Nao Taromaru, Ayuri Nagura, Hiroaki Ishikawa, Koji Suzuki, Ryoji Teradaira, Shuji Hashimoto
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 468(1-2) 185-189, Dec, 2015  Peer-reviewed
  • Hiroya Yamada, Koji Ohashi, Koji Suzuki, Eiji Munetsuna, Yoshitaka Ando, Mirai Yamazaki, Hiroaki Ishikawa, Naohiro Ichino, Ryouji Teradaira, Shuji Hashimoto
    CLINICA CHIMICA ACTA, 446 267-271, Jun, 2015  Peer-reviewed
  • Koji Ohashi, Yoshitaka Ando, Eiji Munetsuna, Hiroya Yamada, Mirai Yamazaki, Ayuri Nagura, Nao Taromaru, Hiroaki Ishikawa, Koji Suzuki, Ryouji Teradaira
    NUTRITION RESEARCH, 35(3) 259-264, Mar, 2015  Peer-reviewed
  • Ishikawa H, Ohashi K, Ogitsu N, Nagamura Y
    Int J Anal Bio-Sci, 3(2) 25-32, 2015  
  • Ishikawa H, Muramatsu C, Ohashi K, Ogitsu N, Nagamura Y
    Int J Anal Bio-Sci, 1(2) 71-76, 2013  
  • 寺平 良治, 石川 浩章, 川井 薫, 堀口 敦史, 大橋 鉱二, 北川 文彦, 平光 伸也, 岩瀬 正嗣, 伊藤 康宏
    心療内科, 10 433-437, 2006  
  • 寺平 良治, 杉本 邦彦, 川井 薫, 石川 浩章, 伊藤 康宏, 平光 伸也, 岩瀬 正嗣
    心療内科, 10 137-141, 2006  
  • 石川 浩章, 前河 裕一, 大橋 鉱二, 荻津 直通, 大島 久二, 長村 洋一
    生物試料分析, 28 452-457, 2005  
  • 石川 浩章, 大橋 鉱二, 荻津 直通, 大島 久二, 長村 洋一
    生物試料分析, 28 445-451, 2005  
  • 石川 浩章, 松澤 健夫, 林 孝典, 大橋 鉱二, 荻津 直通, 大島 久二, 長村 洋一
    藤田学園医学会誌, 28 1-4, 2004  
  • H Ishikawa, T Matsuzawa, K Ohashi, Y Nagamura
    ANNALS OF CLINICAL BIOCHEMISTRY, 40 264-268, May, 2003  Peer-reviewed
  • 石川浩章藤田, 孝, 大橋 鉱二, 石井 潤一, 荻津 直通, 長村 洋一
    生物試料分析, 24 283-288, 2001  
  • 石川浩章, 北川 章, 長村洋一
    医学と生物学, 138(1) 5-7, 1999  

Misc.

 12

Books and Other Publications

 4

Presentations

 64

Teaching Experience

 2

Research Projects

 1

教育方法・教育実践に関する発表、講演等

 1
  • 件名(英語)
    -
    終了年月日(英語)
    2009/08/01
    概要(英語)
    過去3年間の臨床検査技師国家試験対策について 第2回 医療科学部相互研修FD